Cartography Biosciences Series B

Cartography Biosciences is a science pipeline platform company developing cancer immunotherapies. They identify and profile antigens at unprecedented scale using single-cell genomics and proteomics to create a comprehensive antigen atlas, enabling the discovery of safer and more effective drug targets. This approach aims to widen the world of treatable cancers by creating precise, broad, and safe therapeutics for patients.